A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Tuberculosis may seem like a historic malady, but it’s still the world’s deadliest infectious disease. Here’s what you need ...

The modified intention-to-treat population included participants from the safety population who had a prerandomization culture positive for Mycobacterium tuberculosis but excluded participants ...

The primary outcomes were time to sputum culture conversion to negative, sputum culture conversion rates, sputum smear conversion rates, and change in TB score, as well as the rate of TB infection ...